Organic cation transporters in psychiatric and substance use disorders

LE Honan, R Fraser-Spears, LC Daws - Pharmacology & therapeutics, 2023 - Elsevier
Psychiatric and substance use disorders inflict major public health burdens worldwide. Their
widespread burden is compounded by a dearth of effective treatments, underscoring a dire …

Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors

A Ecevitoglu, N Meka, RA Rotolo… - …, 2024 - nature.com
People with depression and other neuropsychiatric disorders can experience motivational
dysfunctions such as fatigue and anergia, which involve reduced exertion of effort in goal …

Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats

M Hersey, M Mereu, CS Jones… - European Journal of …, 2024 - Wiley Online Library
Psychostimulant use disorders (PSUD) are prevalent; however, no FDA‐approved
medications have been made available for treatment. Previous studies have shown that dual …

Contribución del sexo en la respuesta locomotora y en la espinogénesis en neuronas hipocampales asociadas a la administración de anfetamina

JA Cettra-Zarate - rdu.unc.edu.ar
La adicción a drogas es una neuropatología que afecta tanto a mujeres como a hombres y,
si bien este trastorno ha sido estudiado mayormente en hombres, la evidencia indica la …

[HTML][HTML] Stimulant-dependent sleep disorder

BV Vaughn, N Walker - medlink.com
Most CNS stimulant substances have adverse effects on sleep, resulting in sleep
fragmentation, insomnia, and sometimes rebound hypersomnia. Individuals may take these …